Company Filing History:
4 out of 8,384 
1 out of 1,187 
Years Active: 2022-2025
Title: Tyson Moyer: Innovator in Immunomodulatory Fusion Proteins
Introduction
Tyson Moyer is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on fusion proteins. With a total of 4 patents, Moyer's research focuses on developing novel therapeutic approaches to treat cancer.
Latest Patents
Moyer's latest patents include the development of immunomodulatory fusion protein-metal hydroxide complexes. These complexes consist of an immunomodulatory domain that is adsorbed to a metal hydroxide via ligand exchange. The disclosure highlights compositions and methods for using these complexes, particularly in cancer treatment. This innovative approach aims to enhance the efficacy of immunotherapy.
Career Highlights
Throughout his career, Tyson Moyer has worked with prestigious institutions such as the Massachusetts Institute of Technology and The Scripps Research Institute. His work has garnered attention for its potential impact on cancer therapies and immunomodulation.
Collaborations
Moyer has collaborated with notable colleagues, including Darrell J. Irvine and Karl Dane Wittrup. These partnerships have contributed to the advancement of his research and the development of groundbreaking technologies in the field.
Conclusion
Tyson Moyer's contributions to immunology and cancer treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field.